Login to Your Account



Anticipating FDA Nod for HAE Drug, Pharming Raises $16M

By Nuala Moran
Staff Writer

Wednesday, October 16, 2013

LONDON – Pharming Group NV has taken the opportunity to raise €12 million (US$16.2 million) in a private placement after institutional investors started to buy its shares in the market.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription